LENZ
LENZ Therapeutics Inc
3.90$
+5.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | – | +506.6% | +1,037.1% | -99.8% | +286.7% | -5,482.8% | |
| – | – | – | +267.9% | +86.3% | +373.9% | +97.1% | |
| – | +16,990.0% | -246.2% | – | – | -239.1% | – | |
| – | – | +271.5% | +14.9% | -99.5% | +1,460.0% | +76.7% | |
| – | – | +271.5% | +4,113.6% | -87.8% | +421.5% | -51.0% | |
| – | – | – | – | -15.2% | – | – | |
| – | – | +1,288.0% | -99.9% | +13,417.6% | +146.6% | -24.8% | |
| – | +330,083.3% | +1,702.8% | -192.2% | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.